Introduction The liquid biopsy market has emerged as one of the most promising and rapidly evolving segments in the global molecular diagnostics landscape. A liquid biopsy is a minimally invasive test that detects circulating tumor cells (CTCs), cell-free DNA (cfDNA), exosomes, or other biomarkers in bodily fluids—primarily blood—to gain insights into disease presence, progression,...